Venous Disease is Extremely Prevalent and Way Under Diagnosed and Treated: Outlook From a Pioneerlabwebsite20170701Jan 7, 20191 min readUpdated: Jan 9, 2019By CARDIOVASCULAR DISEASE MANAGEMENT: A CASE-BASED APPROACH 2018 FEATURINGPATRICIA THORPE
Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation.
Comments